News Release

AASM congratulates Sleep Medicine Disruptors Innovation Award winners

Attendees selected innovations by Bairitone Health and Noctrix Health for the people’s choice award

Business Announcement

American Academy of Sleep Medicine

Diagnostics award winner Bairitone Health

image: 

Onur Kilic, who has a doctorate in applied physics and is chief technology officer and co-founder of Bairitone Health

view more 

Credit: Photograph by Thomas Heffron, American Academy of Sleep Medicine

DARIEN, IL – The American Academy of Sleep Medicine congratulates Bairitone Health and Noctrix Health, whose innovations were selected as the people’s choice winners of the first AASM Sleep Medicine Disruptors Innovation Award. The votes were cast by attendees of Sleep Medicine Disruptors 2025, which was held in person in Austin, Texas, and livestreamed Nov. 14 - 15.

Eight finalists were previously selected from among 23 entries based on the review of an expert panel of nine AASM members. The AASM assigned each finalist to one of two categories: diagnostics or therapeutics. The finalists gave 15-minute pitch presentations in Austin, and in-person and livestream attendees voted for the winners according to the novelty, practicality, and potential of the innovation to improve sleep health and sleep care by solving a significant and widespread problem.

Innovation Award | Diagnostics

The competition for the diagnostics category was held Friday, Nov. 14.

Winner: Anatomic polysomnogram by Bairitone Health

Bairitone’s platform introduces the first anatomic polysomnogram: a non-invasive, skin-mounted “sleep sonar” sensor patch paired with an AI analysis platform that transforms routine sleep studies into a dynamic, anatomically resolved map of airway behavior during natural sleep (https://www.bairitone.com/).

Honorable Mention

Innovation Award | Therapeutics

The competition for the therapeutics category was held Saturday, Nov. 15.

Winner: Nidra by Noctrix Health

Powered by patented Tonic Motor Activation technology, Nidra is authorized by the FDA to treat restless legs syndrome by delivering high-frequency (4,000 Hz) stimulation to the peroneal nerve to activate afferent low-threshold proprioceptive fibers and induce activation of the tibialis anterior muscle (https://nidrarls.com/).

Honorable Mention

About Sleep Medicine Disruptors

This biennial event attracted clinicians, scientists, technology developers, start-up founders, and other health care innovators, who gathered at the Austin Marriott Downtown for the two-day meeting. Speakers explored technological innovation, artificial intelligence, and other disruptions that are poised to change the landscape of sleep health, patient care, and health care delivery. Keynote presentations were delivered by Dr. Robert Pearl, former CEO of The Permanente Medical Group (Kaiser Permanente), and creativity strategist Natalie Nixon, who has a doctorate in design management.

In addition to nine featured lectures, the event included the presentation of 25 abstracts during two poster sessions and oral presentation sessions. An exhibit hall also featured products and services from leading companies in the industry.

Learn more at aasm.org/disruptors.

###

About the American Academy of Sleep Medicine

Established in 1975, the AASM is a medical association that advances sleep care and enhances sleep health to improve lives. The AASM membership includes more than 9,500 physicians, scientists, and other health care professionals who help people who have sleep disorders. The AASM also accredits 2,300 sleep centers that are providing the highest quality of sleep care across the country (aasm.org).


Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert system.